| Recent CTSO Stock Price | CTSO Stock Predictions | |
| $3.59 | ![]() +2859.61% |
$106.25 |
| Recent CTSO Analyst Ratings Breakdown, Making CTSO Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 2 | 2 | 2 | 2 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 1 | 1 | 1 | 1 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.67 | 1.67 | 1.67 | 1.67 |
For the CTSO stock predictions from the analysts covering Cytosorbents Corp, we have collected all of the individual CTSO stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 4 different analysts covering CTSO (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CTSO stock predictions may vary widely, another useful metric to consider is the median CTSO stock prediction, which represents the price at which half of the analysts
made CTSO stock predictions that were higher and half made CTSO stock predictions that were lower. This makes for a different take on the CTSO stock predictions out there, as compared to average or mean.
And that median across all the individual CTSO stock predictions was: $105.0 as of 2026-10-13.
The very highest of the CTSO stock predictions for one year price target was $200.0, while the very lowest of the CTSO stock predictions in the analyst group was
$15.0 (with a standard deviation of $78.249). Get the latest Zacks research report on CTSO — FREE
Find out: CTSO next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• TSC Stock Predictions
• PIRS Stock Predictions
• BWFG Stock Predictions
• QRHC Stock Predictions
• ZTS Stock Predictions
• IX Stock Predictions
• TPR Stock Predictions
• STAR Stock Predictions
• CFX Stock Predictions
|
|||||||||
|
Quotes delayed 20 minutes
|
Buy (3.33 out of 4) 81st percentile
(ranked higher than approx. 81% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |